BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21896990)

  • 1. Genetic investigation of FOXE1 polyalanine tract in thyroid diseases: new insight on the role of FOXE1 in thyroid carcinoma.
    Kallel R; Belguith-Maalej S; Akdi A; Mnif M; Charfeddine I; Galofré P; Ghorbel A; Abid M; Marcos R; Ayadi H; Velázquez A; Hadj Kacem H
    Cancer Biomark; 2010-2011; 8(1):43-51. PubMed ID: 21896990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype Analyses in the Japanese and Belarusian Populations Reveal Independent Effects of rs965513 and rs1867277 but Do Not Support the Role of FOXE1 Polyalanine Tract Length in Conferring Risk for Papillary Thyroid Carcinoma.
    Nikitski AV; Rogounovitch TI; Bychkov A; Takahashi M; Yoshiura KI; Mitsutake N; Kawaguchi T; Matsuse M; Drozd VM; Demidchik Y; Nishihara E; Hirokawa M; Miyauchi A; Rubanovich AV; Matsuda F; Yamashita S; Saenko VA
    Thyroid; 2017 Feb; 27(2):224-235. PubMed ID: 27824288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of FOXE1 polyalanine repeat region with papillary thyroid cancer.
    Bullock M; Duncan EL; O'Neill C; Tacon L; Sywak M; Sidhu S; Delbridge L; Learoyd D; Robinson BG; Ludgate M; Clifton-Bligh RJ
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1814-9. PubMed ID: 22736773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXE1 polymorphisms are associated with familial and sporadic nonmedullary thyroid cancer susceptibility.
    Tomaz RA; Sousa I; Silva JG; Santos C; Teixeira MR; Leite V; Cavaco BM
    Clin Endocrinol (Oxf); 2012 Dec; 77(6):926-33. PubMed ID: 22882326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl.
    Takahashi M; Saenko VA; Rogounovitch TI; Kawaguchi T; Drozd VM; Takigawa-Imamura H; Akulevich NM; Ratanajaraya C; Mitsutake N; Takamura N; Danilova LI; Lushchik ML; Demidchik YE; Heath S; Yamada R; Lathrop M; Matsuda F; Yamashita S
    Hum Mol Genet; 2010 Jun; 19(12):2516-23. PubMed ID: 20350937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissecting genetic heterogeneity in autoimmune thyroid diseases by subset analysis.
    Tomer Y; Menconi F; Davies TF; Barbesino G; Rocchi R; Pinchera A; Concepcion E; Greenberg DA
    J Autoimmun; 2007; 29(2-3):69-77. PubMed ID: 17644307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and clinical significance of FOXE1 in papillary thyroid carcinoma.
    Fan Y; Ding Z; Yang Z; Deng X; Kang J; Wu B; Zheng Q
    Mol Med Rep; 2013 Jul; 8(1):123-7. PubMed ID: 23715628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLC26A4 expression among autoimmune thyroid tissues.
    Belguith-Maalej S; Rebuffat SA; Charfeddine I; Mnif M; Nadir RF; Abid M; Ghorbel A; Peraldi-Roux S; Ayadi H; Hadj-Kacem H
    Immunobiology; 2011 May; 216(5):571-8. PubMed ID: 21035230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The R620W polymorphism of the protein tyrosine phosphatase 22 gene in autoimmune thyroid diseases and rheumatoid arthritis in the Tunisian population.
    Chabchoub G; Teixiera EP; Maalej A; Ben Hamad M; Bahloul Z; Cornelis F; Ayadi H
    Ann Hum Biol; 2009; 36(3):342-9. PubMed ID: 19343596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroglobulin polymorphisms in Tunisian patients with autoimmune thyroid diseases (AITD).
    Belguith-Maalej S; Hadj Kacem H; Rebai A; Mnif M; Abid M; Ayadi H
    Immunobiology; 2008; 213(7):577-83. PubMed ID: 18656705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The investigation of foxe1 variations in papillary thyroid carcinoma.
    Somuncu E; Karatas A; Ferahman S; Saygili N; Yilmaz E; Ozturk O; Kapan M
    Int J Clin Exp Pathol; 2015; 8(10):13458-64. PubMed ID: 26722557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selected single-nucleotide polymorphisms in FOXE1, SERPINA5, FTO, EVPL, TICAM1 and SCARB1 are associated with papillary and follicular thyroid cancer risk: replication study in a German population.
    Sigurdson AJ; Brenner AV; Roach JA; Goudeva L; Müller JA; Nerlich K; Reiners C; Schwab R; Pfeiffer L; Waldenberger M; Braganza M; Xu L; Sturgis EM; Yeager M; Chanock SJ; Pfeiffer RM; Abend M; Port M
    Carcinogenesis; 2016 Jul; 37(7):677-684. PubMed ID: 27207655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of FOXE1 expression in papillary thyroid carcinoma by immunohistochemistry.
    Bychkov A; Saenko V; Nakashima M; Mitsutake N; Rogounovitch T; Nikitski A; Orim F; Yamashita S
    Thyroid; 2013 Jul; 23(7):817-28. PubMed ID: 23327367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of FOXE1 polyalanine repeat region with thyroid cancer is dependent on tumour size.
    Raimundo J; Alvelos MI; Azevedo T; Martins T; Rodrigues FJ; Lemos MC
    Clin Endocrinol (Oxf); 2017 Feb; 86(2):243-246. PubMed ID: 27474100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association of polymorphism of protein tyrosine phosphatase nonreceptor-22 gene with AITD].
    Yu ZY; Zhang JA; Maier HB; Wang Y; Xiao WX; Quan Y; Dong BN
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Aug; 24(8):804-7. PubMed ID: 18687223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors.
    Landa I; Ruiz-Llorente S; Montero-Conde C; Inglada-Pérez L; Schiavi F; Leskelä S; Pita G; Milne R; Maravall J; Ramos I; Andía V; Rodríguez-Poyo P; Jara-Albarrán A; Meoro A; del Peso C; Arribas L; Iglesias P; Caballero J; Serrano J; Picó A; Pomares F; Giménez G; López-Mondéjar P; Castello R; Merante-Boschin I; Pelizzo MR; Mauricio D; Opocher G; Rodríguez-Antona C; González-Neira A; Matías-Guiu X; Santisteban P; Robledo M
    PLoS Genet; 2009 Sep; 5(9):e1000637. PubMed ID: 19730683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of ATM and FOXE1 (TTF2) to risk of papillary thyroid carcinoma in Belarusian children exposed to radiation.
    Damiola F; Byrnes G; Moissonnier M; Pertesi M; Deltour I; Fillon A; Le Calvez-Kelm F; Tenet V; McKay-Chopin S; McKay JD; Malakhova I; Masyakin V; Cardis E; Lesueur F; Kesminiene A
    Int J Cancer; 2014 Apr; 134(7):1659-68. PubMed ID: 24105688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network-Based Analysis Reveals Association of FOXE1 Gene Polymorphisms in Thyroid Cancer Patients; A Case-Control Study in Southeast of Iran.
    Mehrazin A; Safarpour H; Davoudi ST; Parsamanesh N; Saeedi F; Miri-Moghaddam E
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2771-2776. PubMed ID: 32986379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXE1 polyalanine tract length polymorphism in patients with thyroid hemiagenesis and subjects with normal thyroid.
    Szczepanek E; Ruchala M; Szaflarski W; Budny B; Kilinska L; Jaroniec M; Niedziela M; Zabel M; Sowinski J
    Horm Res Paediatr; 2011; 75(5):329-34. PubMed ID: 21311165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation into FOXE1 polyalanine tract length in premature ovarian failure.
    Watkins WJ; Harris SE; Craven MJ; Vincent AL; Winship IM; Gersak K; Shelling AN
    Mol Hum Reprod; 2006 Mar; 12(3):145-9. PubMed ID: 16481406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.